Our news team covers important developments in Alzheimer research and related fields of biomedicine, basic science and technology. Updates on drug development are listed under Drug News. Archived stories can be retrieved through our News search interface. All stories are based on original reporting and writing by our news team unless otherwise indicated.
Note: We strive to include all Alzheimer-relevant basic and clinical
research citations in our database, and to provide balanced reports of
major developments in our News department. Any omissions are unintended,
and we very much appreciated being notified about them. Contact us.
Announcing Alzheimer's Research & Therapy, a new online peer-reviewed journal which publishes open access research articles of outstanding quality in Alzheimer's research.
Should the FDA be allowed to use data from overseas clinical trials?
Absolutely, we are running out of viable subjects in the U.S.
Yes, so long as the data is reliable
No, the trials are not as rigorous
No, the data should be repeated in the U.S.
No, the drug sponsors are just trying to cut corners